(Q46426580)

22 December 2017

title

Inflammatory markers in women with a recent history of gestational diabetes mellitus (English)

1 reference

22 December 2017

0 references

0 references

A Di Benedetto

1

1 reference

22 December 2017

G T Russo

2

1 reference

22 December 2017

F Corrado

3

1 reference

22 December 2017

E Di Cesare

4

1 reference

22 December 2017

E Alessi

5

1 reference

22 December 2017

G Nicocia

6

1 reference

22 December 2017

R D'Anna

7

1 reference

22 December 2017

D Cucinotta

8

1 reference

22 December 2017

language of work or name

1 reference

1 January 2005

1 reference

22 December 2017

Journal of Endocrinological Investigation

published in

1 reference

22 December 2017

volume

28

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

34-38

1 reference

22 December 2017

Insulin resistance syndrome in women with prior history of gestational diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

First-trimester C-reactive protein and subsequent gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

C-reactive protein and gestational diabetes: the central role of maternal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Criteria for screening tests for gestational diabetes

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FBF03345527

21 January 2018

12 December 2020

Gestational Glucose Intolerance in Multiple Pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345527

Lipid levels in former gestational diabetic mothers

21 January 2018

1 reference

12 December 2020

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

1 reference

12 December 2020

Significance of chemokines and activated platelets in patients with diabetes

1 reference

12 December 2020

Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese

1 reference

12 December 2020

Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345527

1 reference

22 December 2017

1 reference

22 December 2017